Human neuroblastomas can arise either during embryogenesis or post-natally from stem cells of the peripheral sympathetic nervous system. These tumours represent highly malignant solid neoplasms. They show various stages of development which are reflected by particular molecular structures on the cell surface (Hughes et al., 1974; Evans et al., 1976; Momoi et al., 1980) . The phenotype of neuroblastoma can be identified using a panel of monoclonal antibodies (MAb) specific for various cell surface molecules expressed at different stages of development (Kemshead & Black, 1980; Kemshead et al., 1983; Schonmann et al., 1986) .
The monoclonal antibody CE7 possesses so far a unique specificity in that it recognises a glycoprotein of 185 kD particularly expressed on the surface of all neuroblastoma cells independently of their histological grade, and other neoplastically transformed sympatho-adreno-medullary cells.
CE7 does not bind to cells or tumours of non-neuroectodermal origin. Since no reactivity toward hemopoietic cells has been observed, this MAb might be used to remove tumour cells from the bone marrow. Up to now it has been used for tumour diagnosis (Sch6nmann et al., 1986) and for in vivo localisation of the tumour (Rentsch et al., 1988) . From the original CE7-yl/c secreting hybridoma, isotype variants were selected which bind to the same epitope as the original CE7 and show the same N-terminal amino-acid sequence. Their functionally rearranged variable H and L chain gene segments represent the same V region rearrangements, but they use different H chain genes. For example, isotype switch variants of CE7 have been obtained that produces antibodies exhibiting complement-mediated lysis of neuroblastoma cells, whereas antibodies of the original CE7 hybridoma are virtually inactive in this regard (d'Uscio et al., in preparation) .
The purpose of this study was to select isotype switch variants that produce antibodies which supported antibodydependent cell-mediated cytotoxicity (ADCC), an effector function believed to be involved in the elimination of antibody-coated tumour cells (Pearson, 1978; Hellstrom et al., 1981; Imai et al., 1982) , and to test various Fc IgG receptor (FcyR) positive cells for their capacity to mediate ADCC using the antibodies of the selected variants. FcRT positive cell types reported to have ADCC activity include cells of the monocyte/macrophage series (Katz et al., 1980; Ralph et al., 1980) , some granulocytes (Conkling et al., 1982) and cells belonging to the NK/K cell lineage (de Lanzaduri et al., 1979 Identification and selection of isotype switch variants hydridomas The identification of switch-variants was achieved by analysis of culture supernatants using an isotype-specific sandwich ELISA. Briefly, 96-well polystyrene microtitre plates (NUNC, Roskilde, Denmark, Typ I 4-39454) were coated with 0.5 pg of goat anti-mouse isotype-specific reagent in 100 jil PBS pH 8.0 by overnight incubation at room temperature. The plates were washed with PBS containing 0.20% Tween 20 and 0.02% NaN3. Remaining free binding sites were blocked by incubation for 30 min at 37°C with a 1% casein hydrolysate (Oxoid Ltd., Basingstoke, UK) solution made with PBS containing 5% Tween 20 and 0.2% NaN3.
The culture supernatants (100 gLl) were added to the coated plates, and incubated for 2 h at 37°C. Alkaline phosphataselabelled goat anti-mouse isotype was then added in 100 fsl PBS/1% casein hydrolysate/5% Tween 20/0.02% NaN3. After 2h at 37°C, p-nitrophenylphosphate (1.5mgml-') in 1 M diethanolamine pH 9.8/0.01% MgCl2/0.02% NaN3 was added and the absorbance was measured after 30-60 min at 37°C in an automated Titertek Multiscan MC ELISA reader (Flow, Irvine, Scotland).
Neuroblastoma-binding of CE7 antibodies
The neuroblastoma reactivity of CE7 isotype variants was tested by a cell-ELISA (Feit et al., 1983) . That is, Vbottomed PVC microtitre plates (Dynatech, Kloten, Switzerland) were preincubated with PBS/i % BSA/l .5 mM MgCl2/ 2 mM P-mercaptoethanol (PBS-BSA) for 30 min at 37C.
Viable, exponentially growing neurobastoma cells were harvested in Puck's A buffer (Reynolds & Maples, 1985) , sonicated for 1-2 s to dissociate clumps and counted in a haemocytometer. Binding studies of CE7 antibody were performed by using 7.5 x 105 neuroblastoma cells/well. After 2 h at 4°C the plates were centrifuged at 200 g for 5 min and the cells resuspenced in one drop of PBS-BSA. After two washings, with 150 fil PBS-BSA, P-galactosidase-labelled goat anti-mouse isotype-specific antibody was added in 100 ,l PBS-BSA and the plates were incubated overnight at 4°C.
Then after four washings, o-nitro-phenyl-p-D-galactopyranoside (1 mg ml-') in PBS/i1.5 mM MgCl2/100 mM P-mercaptoethanol was added and the plates were incubated for 60-90 min at 37°C. The reaction was stopped with 0.5 M sodium carbonate and the absorbance was measured in a Titertek Multiscan MC ELISA reader.
Effector cellpreparation Peripheral blood mononuclear cells (PBMC) were isolated from buffy coats of 450 ml blood samples by isopycnic centrifugation over Ficoll-Hypaque.
Nonadherent lymphocytes (T cells and NK/K cells) were isolated from PBMC by nylon-wool fractionation (Julius et al., 1973) . PBMC (50-100 x 106) were loaded onto a 0.6 g nylon wool column (Fenwal, Deerfield, IL) . After 1 h of incubation at 37°C, nonadherent cells were eluted with EMEM containing 2.5% HEPES, 5% FCS at pH 7.3, washed with PBS and resuspended in complete medium.
Monocytes were purified by elutriation-centrifugation (Clemetson et al., 1985) in a Beckman J2-21 M centrifuge fitted with a J-6B rotor and a Beckman type elutriation chamber. The flow rate was held constant at 17.3 ml min-' by gradual reduction of the rotation speed. The monocyteenriched fractions were pooled, washed and resuspended in complete medium; they contained 95-99% monocytes.
Macrophages were derived from monocytes as described by Jungi and Hafner (1986) . PBMC were incubated for 1 h in tissue culture flasks containing RPMI-1640 supplemented with HEPES (25 mM) and 2% heat inactivated homologous human serum (ABRh-). Nonadherent cells were removed by rinsing, and adherent cells were cultured overnight in medium containing 10% serum. Then, adherent cells were dislodged by vortexing, washed with PBS, and resuspended in medium supplemented with 15% serum (5 x 105 adherent cellsml-'). The cells, now consisting mainly of monocytes (;90%) were placed in sealed bags made from hydrophobic teflon foil (DuPont de Nemours). After 1 week, monocytes had differentiated to macrophages as evidenced by an increase in size, enhanced phagocytosis capacity, loss of myeloperoxidase and other functional alterations (Andreesen et al., 1983; Jungi & Hafner, 1986; Jungi & Peterhans, 1988) . These cells were harvested between day 7 and 9 from the bags, washed with PBS and resuspended in ADCC medium. In some experiments, macrophages were exposed for the last 2 days of culture to rIFN-y (500 U ml-'). This dose had been found to be optimal with respect to several activation parameters (Jungi et al., 1989) . In particular, it was shown to increase the number of high-affinity FcRIyI/CD64, but not of low-affinity FcRyII/CD32 or FcRyIII/CD16 (Jungi & Peterhans, 1988 ).
Target cell preparation
Viable, exponentially growing IMR-32 neuroblastoma cells were harvested in Puck's A buffer supplemented with 1 mM EDTA and 10 mM HEPES (Reynolds & Maples, 1985) . After 5 min centrifugation at 200 g and two washings with complete medium, the cells were sonicated for 1-2 s to disperse clumps and counted in a haemocytometer. Cells (5 x 106) were labelled with 50 JACi 5"Cr sodium chromate (specific activity 600-900 mCi mg-L Cr) in 150 ul heat inactivated FCS for 1 h at 37°C in 5% CO2. The labelling culture was gently shaken every 15 min. After four washings the cells were resuspended at the density required for ADCC assay.
Determination of antibody-dependent cellular cytotoxicity ADCC was assayed in V-bottomed PVC microtitre plates (Dynatech, Kloten, Switzerland) which had been preincu-bated with complete medium for 1 h at 37°C. In some experiments round-bottomed polystyrene microtitre plates (Greiner, Niirtingen, Germany) 
Results

Isolation of switch variants
The parent hybridoma cell line CE7 producingyl/x antibody had been growing in culture for more than 3 months and the selected CE7'y2b hybridoma for 1 month without subcloning. The isolation ofy2b and '2a variants was made by sequential subculturing. The original CE771 was subcultured to obtain 72b and then72b was subcultured to obtainy2a, as originally described by Muller and Rajewsky (1983) .
In a first round of selection, starting with 1.5 x106 CE7'y1 cells at a density of 3,000 cells/well, 48 'y2b positive wells were obtained. The variants were identified by sandwich ELISA using two polyclonal isotype-specific antibodies. Selected positive cultures were subjected to a second round of enrichment at a density of 50 cells/well. The cultures producing the relevant isotype were cloned three times by limiting dilution. By using the same procedure 30 'j2a positive wells were detected from 1.5 x 106 cells of a selected CE7-y2b clone. For both isotypes, selected variants were obtained at a frequency of 1 to 2 x 10-'. The cloned switch variants were further selected for their reactivity with neuroblastoma cells using a cell ELISA with viable IMR-32 cells and polyclonal isotype-specific P-galactosidose labelled antibodies. From the 11 selected y2b secreting CE7 clones, three bound to IMR-32, SK-N-AS and SK-N-MC and from seven selected v2a clones, five bound to these neuroblastomas lines. The three CE7y2b variants secreted only the y2b isotype, whereas clones which exclusively secreted 72a antibodies could not be found. All five CE7y2a secreting clones expressed both '2a andy2b isotypes after three additional subclonings. As demonstrated by surface staining with FITC labelled antibodies more than 99% of cells in all cultures were double producers. The composition of the antibodies secreted by a CE7y2a positive clone after purification was 55% y2a and 45% 72b. The 72a antibody was separated from 72b by HPLC using Bakerbond columns (d'Uscio et al., in preparation) .
The biochemical and molecular genetic properties of three CE7 isotype variants were extensively studied and published separately (d'Uscio et al., in preparation). The antibodies use identical VH and VL gene segments but distinct CH. The H chains are N-terminally blocked and the L chains were identical in their FRI region but different to the P3Ul line.
Binding capacity and characteristics of monomeric CE7"1 All CE7 antibodies, regardless of their isotype, bound to IMR-32 cells as demonstrated in a cell-ELISA using polyclonal isotype-specific labelled antibodies (Figure 1) . The titration of CE7 antibodies against a constant number of IMR-32 cell survival in the presence of different cell populations of PBMC (effector cells) was measured with and without the addition of antibody (CE7y2a) in a 6 h assay. The number of IMR-32 target cells addedper well was 2,500. Figure 2 summarises the results obtained with mononuclear cells, purified monocytes and nonadherent cells as effectors at E/T ratios of 40:1 and 80:1. With the addition of CE7-y2a antibodies, target cell death was slightly but not significantly increased.
=A-Mononuclear cells Discussion
In the present study, we analysed anti-neuroblastoma cytolytic effector cells in ADCC assays with CE7yl, y2a and y2b isotype-switch variants, using IMR-32 cells as a target. In contrast to the above, IMR-32 cell survival was distinctly different in the presences of macrophages (Figure 3 ). In the absence of antibody, the rate of death was very low. With the addition of antibody, target cell killing was markedly increased. The E/T ratios used were 20:1 and 5:1. Pre-exposure of macrophages to rIFN-y increased both non-specific and specific (antibody-mediated) killing. A post-lysis uptake of 5"Cr by macrophages from the supernatant could be excluded (Hogg, 1988) and up to now, three types of FcRy have been found on peripheral blood leukocytes. They are referred to as FcR7yI/CD64, FcR'yII/CD32 and FcRTyIII/ CD16, respectively. These FcR are distinguished antigenically, structurally, by isotype binding specificity and by binding affinity (Anderson & Looney, 1986; Fanger et al., 1989) .
FcRyI, being mainly expressed on cells of the monocytemacrophage lineage, is unique in that it binds monomeric human IgGl and IgG3, and murine IgG2a and IgG3. It could therefore be involved in the CE7-y2a-mediated lysis of IMR-32 cells. This is consistent with the findings of Steplewski et al (1983) who demonstrated lysis of human colon carcinoma cells by IgG2a-armed monocytoid effectors.
In a study similar to ours, IgG2b was also active in mediating ADCC, although to a lower degree, than IgG2a (Kipps et al., 1985) . In their study, unseparated mononuclear cells served as effector cells. Their effector cell preparation contained cells of the NK/K lineage which express the low affinity FcR^yIII. Thus, so far the consensus is that 72a is the most effective murine isotype mediating ADCC regardless of the effector cell involved. The hypothesis that FcR'yI mediates lysis of CE7y2a-covered targets could be proven by the use of blocking antibodies specific for FcR'?I; these antibodies were unavailable at the time of this study. In the present study, exposure of macrophages to rIFN-y, known to upregulate selectively FcR'yI/CD64 (Jungi & Peterhans, 1988) , promoted enhanced CE7y2a-mediated lysis (Figure 3 ).
The antibody CE7, which is one of the few neuroblastoma selective monoclonal antibodies but possesses some unique features (Momoi et al., 1980; Reynolds & Smith, 1982; Cheung et al., 1985; Sch6nmann et al., 1986) , has been used hitherto for diagnostic purposes. For therapeutic use an antibody should not only be specific, but also should mediate appropriate effector functions, such as activation of the complement system and the induction of ADCC. The present study demonstrates that the strategy of selecting isotype switch variants can fulfill these requirements. The y2a variant of CE7 described here mediates both ADCC and complement fixation while the original 71 isotype is deficient in both respects.
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